Biognosys Launches Spectronaut 19 and Presents Advances with Its Research Platforms at the ASMS 2024 Annual Conference

Core Insights - Biognosys will showcase its advancements in mass spectrometry-based proteomics at the ASMS Annual Conference, including the launch of Spectronaut 19 and other innovative solutions [1][2] Group 1: Product Launches and Features - Spectronaut 19 introduces significant improvements in peptide and protein identification, candidate discovery rates, scalability for large-scale analysis, and support for novel workflows [3][6] - The new P2 Plasma Enrichment method enhances the TrueDiscovery platform, offering superior performance for deep plasma proteomics and is available as a CRO service or in-house method [5][6] - TrueTarget® platform features a high-throughput LiP-MS workflow for efficient drug target deconvolution screening, improving target identification and reducing measurement time [8][6] Group 2: Scientific Presentations and Engagements - Biognosys will host two breakfast seminars, four oral presentations, and eleven posters at the ASMS conference, highlighting the capabilities of Spectronaut 19 and other technologies [2][4] - Key presentations include topics on quantitative proteomics and high-dimensional phosphoproteomics, showcasing the software's application in various research areas [4][7] Group 3: Data Insights Solutions - DigitalProteome™ database provides insights into protein expression and supports biomarker discovery, featuring profiles from 22 healthy tissues and available for biopharma research [9][10] - Proteoverse™ platform allows for data visualization and exploration, enabling users to extract biological insights and examine peptide-level structures [10][9]